Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158(1):084-091 | DOI: 10.5507/bp.2012.087

Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs

Marie Berkovaa, Zdenek Berkab, Eva Topinkovaa
a Department of Geriatrics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
b Department of Internal Medicine II - Gastroenterology and Hepatology, University Hospital Olomouc

Background: Severe hyperkalemia is a life threatening condition that can cause fatal rhythm disturbance and terminal heart arrest. The most common cause of hyperkalemia in older patients is that of iatrogenic medication-related etiology due to associated polymorbidity, polypharmacy and reduced reserve metabolic capacity. The aim of this paper is to increase awareness in the clinicians of the risk of hyperkalemia in elderly patients treated by potassium sparing drugs.

Methods and Results: We present two case reports of hyperkalemia ≥ 9.0 mmol/L induced by potassium sparing medications with cardiac arrhythmias and severe ECG changes including atrial asystole, disturbance of intraventricular conduction and morphological changes such as tenting T waves and deformed wide QRS complexes. The most frequent causes of hyperkalemia in elderly patients are discussed and electrocardiogram changes and arrhythmias in hyperkalemia are analyzed, as well as their treatment and prevention.

Conclusion: Potassium sparing drug therapy in older persons requires more frequent monitoring especially when drugs or their doses are changed, or during concomitant acute illness.

Keywords: hyperkalemia, electrocardiogram, potassium sparing drugs, elderly patients

Received: February 2, 2012; Prepublished online: October 31, 2012; Published: April 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Berkova, M., Berka, Z., & Topinkova, E. (2014). Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs. Biomedical papers158(1), 084-091. doi: 10.5507/bp.2012.087
Download citation

References

  1. Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, Campbell RC, Love TE, Aronow WS, Allman RM, Bakris GL, Ahmed A. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail 2010;3:253-60. Go to original source... Go to PubMed...
  2. Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol 2010;5:531-8. Go to original source... Go to PubMed...
  3. Bozkurt B, Agoston I, Knowlton AA. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol 2003;41:211-4. Go to original source... Go to PubMed...
  4. Yüksel S, Çölbay M, AcartürkG, Uslan I, Karaman O, Maralcan M, Yavuz Y. Severe Hyperkalemia: A Retrospective Analysis. European Journal of General Medicine 2008;5(2):80-3. Go to original source...
  5. Sica DA. Hyperkalemia risk in chronic kidney disease. deterrent to the use of aldosterone receptor antagonism or not. Hypertension 2009;53:754-60. Go to original source... Go to PubMed...
  6. Palmer BF. Hypertension management in patients with chronic kidney disease. Curr Hypertens Rep 2008;10(5):367-73. Go to original source... Go to PubMed...
  7. Schrier RW, Masoumi A, Elhassan E. Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol 2010;5:1132-40. Go to original source... Go to PubMed...
  8. Slagman MC, Navis G, Laverman GD. Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease. Curr Opin Nephrol Hypertens 2010;19:140-52. Go to original source... Go to PubMed...
  9. Cavallari LH, Groo VL, Viana MA, Dai Y, Patel SR, Stamos TD. Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. Pharmacotherapy 2010;30:1-9. Go to original source... Go to PubMed...
  10. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009;169:1156-62. Go to original source... Go to PubMed...
  11. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51. Go to original source... Go to PubMed...
  12. Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM. Spironolactone use and renal toxicity: population based longitudinal analysis. BMJ 2010;340:c1768. Go to original source... Go to PubMed...
  13. Sadjadi SA, McMillan JI, Jaipaul N, Blakely P. A comparative study of the prevalence of hyperkalemia with the use of angiotenstin-converting enzyme inhibitors versus angiotensin receptor blockers. Dovepress J 2009,5:547-52. Go to original source...
  14. McIntyre WF, Femenía F, Arce M, Pérez-Riera AR, Baranchuk A. Importance of early electrocardiographis recognition and timely management of hyperkalemia in geriatric patients. Exp Clin Cardiol 2011;16(2):47-50.
  15. Weisberg LS. Management of severe hyperkalemia. Crit Care Med 2008;36:3246-51. Go to original source... Go to PubMed...
  16. Kubešová H, Holík J, Šipr K, Bogrová I. Farmakoterapie starších klientů praktického lékaře - teorie a skutečnost. Geriatria 2000,6:27-32.
  17. Tesař V. Hypokalémie a hyperkalémie. Postgraduální medicína 2010;12(5):574-8.
  18. Nyirenda MJ, Tang JI, Padfield PL, Seckhl JR. Hyperkalaemia. Br Med J 2009; 339:1019-24. Go to original source... Go to PubMed...
  19. Kokot F, Hyla-Klekot L. Drug-induced abnormalities of potassium metabolism. Polskie Archiwum Medycyny Wewnetrznej 2008;118, pp. 431-3. Go to original source... Go to PubMed...
  20. Khanna A, White WB. The management of hyperkalemia in patients with cardiovascular disease. Am J Med 2009;122, pp. 215-21. Go to original source... Go to PubMed...
  21. Venzin RM, Cohen CD, Maggiorini M, Wüthrich RP. Aliskiren-associated acute renal failure with hyperkalemia. Clin Nephrol 2009;98:326-8. Go to original source... Go to PubMed...
  22. Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 1995;71:575-86. Go to original source... Go to PubMed...
  23. Parham WA, Mehdirad AA, Biermann KM, BS, Fredman CS. Hyperkalemia Revisited, Tex Heart Inst J 2006;33(1):40-7.
  24. Walter RB, Bachli EB. Images in cardiology. Near fatal arrhythmia caused by hyperkalemia. Heart 2002;88(6):578. Go to original source... Go to PubMed...
  25. Luzza F, Carey S, Oreto G. Images in cardiology. An unusual hyperkalemia induced block. Heart 2001;86:686 doi:10.1136/heart.86.6.686 Go to original source... Go to PubMed...
  26. Manohar N, Young ML. Rate dependent bundle branch block induced by hyperkalemia. Pacing Clin Electrophysiol 2003;26(9):1909-10. Go to original source... Go to PubMed...
  27. Wang K, Asinger RW, Marriott HJ. ST segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003;349(22):2128-35. Go to original source... Go to PubMed...
  28. Vereckei A. Inferior wall pseudoinfarction pattern due to hyperkalemia. Pace 2003;26:2181-4. Go to original source... Go to PubMed...
  29. Kim NH, Oh SK, Jeong JW. Hyperkalemia induced complete atrioventricular block with a narrow QRS complex. Heart 2005;91:e5 doi:10.1136/hrt.2004.046524 Go to original source... Go to PubMed...
  30. Goranitou G, Stavrianaki D, Babalis D. Wide QRS tachycardia caused by severe hyperkalemia and digoxin intoxication. Acta Cardiol 2005;60(4):437-41. Go to original source... Go to PubMed...
  31. Tiberti G, Bana G, Bossi M. Complete atrioventricular block with widened QRS complex during hyperkalemia. Pacing Clin Electrophysiol 1998;21(7):1480-2. Go to original source... Go to PubMed...
  32. Seto A, Murakami M, Fukuyama H, Kuniyuki N, Kazuyoshi A, Takenakana I, Kadoya T. Ventricular tachycardia caused by hyperkalemia after administration of hypertonic mannitol. Anesthesiology 2000;93(5):1359-61. Go to original source... Go to PubMed...
  33. Sims DB, Sperling LS. ST-Segment Elevation Resulting From Hyperkalemia. Circulation. 2007;116:e2-e4. Go to original source... Go to PubMed...
  34. McGuigan J, Robertson S, Isles C. Life threatening hyperkalemia with diarrhoea during ACE inhibition. Emerg Med J 2005;22:154-5. doi:10.1136/emj.2003.011734 Go to original source... Go to PubMed...
  35. Barold SS, Falkoff MD, Ong LS, Heinle RA. Hyperkalemia induced failure of atrial capture during dual-chamber cardiac pacing. J Am Coll Cardiol 1987;10(2):467-9. Go to original source... Go to PubMed...
  36. Kahloon MU, Aslam AK, Aslam AF, Wilbur SL, Vasavada BC, Khan IA. Hyperkalemia induced failure of atrial and ventricular pacemaker capture. Int J Cardiol 2005;105(2):224-6. Go to original source... Go to PubMed...
  37. Poggio R, Grancelli HO, Miriuka SG. Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism. Postgrad Med J 2010;86:136-42. doi:10.1136/pgmj.2008.072058 Go to original source... Go to PubMed...
  38. Pajerek J, Štolcová A, Fialka J. Otrava kaliem. Pediatria pre prax, 2006;1:42-4.
  39. Carvalhana V, Burry L, Lapinsky SE. Management of severe hyperkalemia without hemodialysis: Case report and literature review. J Crit Care 2006;21(4):316-21. Go to original source... Go to PubMed...
  40. ECC Committee: American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Circulation 2005;112(24 Suppl):IV1-203.
  41. Sood MM, Sood AR, Richardson R. Emergency management and commonly encountered outpatient scenarios in patients with hyperkalemia. Mayo Clin Proc 2007;82(12):1553-61. Go to original source... Go to PubMed...
  42. Chardos J. Timing of Administration of Beta-Agonists. Mayo Clin Proc 2008;83(3):368-73. Go to original source... Go to PubMed...
  43. Mandelberg A, Krupnik Z, Houri S, Smetana S, Gilad E, Matas Z, Priel IE. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? how safe? Chest 1999;115(3):617-22. Go to original source... Go to PubMed...
  44. Dimmitt SB. Salbutamol unsafe in hyperkalaemia. Brit Med J 2009;339/b4114. doi:10.1136/bmj.b4114 Go to original source... Go to PubMed...
  45. Kamel SK, Wei C. Controversial issues in the treatment of hyperkalaemia. NDT 2003;18(111):2215-18. Go to original source... Go to PubMed...
  46. Mc Veigh G, Maxwell P, O´Donnell S. Guidelines for the treatment of hyperkalaemia in adults. 2008, pp 13-4. Belfast Health and Social Care Trust 2008, GAIN, Stormont Belfast. ISBN 978-1-906805-02-9.
  47. Sørensen MV, Matos JE, Praetorius HA, Leipziger J. Colonic potassium handling. Pflugers Arch 2010;459(5):645-56. Go to original source... Go to PubMed...
  48. Chakraborty B, Rahman M, Ahmed QS, Rahman MM. Life threatening hyperkalemia requiring prolonged temporary pacing support: A case report and an analysis of electrocardiographic ganges. Orion Med J 2006;25:411-3.
  49. Mckellar G, Alfonzo A, Isles C.Hyperkalemia: causes, electrocardiographic changes and management. J R Coll. Physicians Edinb 2006;36:5-11.
  50. Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang I-Z. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J 2011;32(7):820-8. Go to original source... Go to PubMed...